In Vitro Activity of a Novel Glucan Synthase Inhibitor, SCY-078, against Clinical Isolates of Candida auris

Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00435-17. doi: 10.1128/AAC.00435-17. Print 2017 Jul.

Authors

Elizabeth L Berkow¹, David Angulo², Shawn R Lockhart³

Affiliations

¹ Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA kuu4@cdc.gov.
² SCYNEXIS, Inc., Jersey City, New Jersey, USA.
³ Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

No abstract available

Keywords: Candida auris; SCY-078.

Publication types

Letter

MeSH terms

Antifungal Agents / pharmacology*
Candida / drug effects*
Candida / isolation & purification
Candidiasis / microbiology*
Drug Resistance, Fungal
Glycosides / pharmacology*
Humans
Microbial Sensitivity Tests
Triterpenes / pharmacology*

Substances

Antifungal Agents
Glycosides
Triterpenes
ibrexafungerp